FIA
ABMD

FNY Investment Advisers’s Abiomed Inc ABMD Stock Holding History

FNY Investment Advisers’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-430
Closed -$73K – 919
2019
Q4 		$73K Buy
+430
New +$79.7K 0.02% 414
2019
Q1 		– Sell
-34
Closed -$11K – 1023
2018
Q4 		$11K Buy
+34
New +$11.8K ﹤0.01% 399
2018
Q3 		– Sell
-8
Closed -$3K – 1384
2018
Q2 		$3K Buy
+8
New +$2.9K ﹤0.01% 759

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

FNY Investment Advisers's ABMD Position: Q1 2020 in Review

FNY Investment Advisers sold out of Abiomed Inc (ABMD) in Q1 2020, closing a stake of 430 shares — an estimated $73K sold.

FNY Investment Advisers first reported a position in ABMD in Q2 2018 and held it in 3 quarters. The position peaked at $73K in Q4 2019. 412 funds tracked by Wall St. Rank hold ABMD as of Q1 2020.

  • FNY Investment Advisers reported no remaining Abiomed Inc position as of Q1 2020 after selling out during the quarter.
  • FNY Investment Advisers sold 430 Abiomed Inc shares in Q1 2020, an estimated $73K.
  • FNY Investment Advisers first reported a position in Abiomed Inc in Q2 2018 and held it in 3 quarters.
  • FNY Investment Advisers's Abiomed Inc position peaked at $73K in Q4 2019.
  • 412 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2020.

Based on FNY Investment Advisers's 13F filing for Q1 2020, filed 9 Apr 2020.